Pregnant women who are at least 20 weeks pregnant and contract chickenpox are typically treated with oral acyclovir if they seek medical attention within 24 hours of developing the rash. Women who were not born and raised in the UK are at a higher risk of contracting chickenpox when they move to the country. The RCOG recommends prescribing oral acyclovir to pregnant women with chickenpox who are at least 20 weeks pregnant and have developed the rash within 24 hours. acyclovir may also be considered for women who are less than 20 weeks pregnant. If a woman contracts chickenpox before 28 weeks of pregnancy, she should be referred to a fetal medicine specialist five weeks after the infection. The chickenpox vaccine cannot be administered during pregnancy, and VZIG is not effective once the rash has developed. In cases where there is clear clinical evidence of chickenpox infection, antibody testing is unnecessary. Pregnant women with chickenpox should be monitored daily, and if they exhibit signs of severe or complicated chickenpox, they should be referred to a specialist immediately. Adults with chickenpox are at a higher risk of complications such as pneumonia, hepatitis, and encephalitis, and in rare cases, death, so proper assessment and management are crucial.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

Understanding Placenta Praevia

Placenta praevia is a condition where the placenta is located wholly or partially in the lower uterine segment. It is a relatively rare condition, with only 5% of women having a low-lying placenta when scanned at 16-20 weeks gestation. However, the incidence at delivery is only 0.5%, as most placentas tend to rise away from the cervix.

There are several factors associated with placenta praevia, including multiparity, multiple pregnancy, and embryos implanting on a lower segment scar from a previous caesarean section. Clinical features of placenta praevia include shock in proportion to visible loss, no pain, a non-tender uterus, abnormal lie and presentation, and a usually normal fetal heart. Coagulation problems are rare, and small bleeds may occur before larger ones.

Diagnosis of placenta praevia should not involve digital vaginal examination before an ultrasound, as this may provoke severe haemorrhage. The condition is often picked up on routine 20-week abdominal ultrasounds, but the Royal College of Obstetricians and Gynaecologists recommends the use of transvaginal ultrasound for improved accuracy and safety. Placenta praevia is classified into four grades, with grade IV being the most severe, where the placenta completely covers the internal os.

In summary, placenta praevia is a rare condition that can have serious consequences if not diagnosed and managed appropriately. It is important for healthcare professionals to be aware of the associated factors and clinical features, and to use appropriate diagnostic methods for accurate grading and management.

Admission or urgent assessment is needed for a pregnant patient experiencing severe nausea and vomiting with weight loss. Routine referral to obstetrics, prescribing oral domperidone, or prescribing oral prochlorperazine are all incorrect options. An obstetric assessment may consider the use of IV anti-emetics. Delaying assessment increases the risk of complications.

Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.

Breastfeeding mothers should avoid taking sulfonylureas (such as gliclazide) as there is a potential risk of causing hypoglycemia in newborns. Similarly, exenatide, liraglutide, and sitagliptin should also be avoided during breastfeeding. However, it is safe to use metformin while breastfeeding.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

The primary concern in eclampsia is to manage seizures, which can be prevented and treated with magnesium sulphate as the first-line treatment. If magnesium sulphate is not available or ineffective, benzodiazepines like midazolam can be considered. Additionally, due to high blood pressure, antihypertensive drugs like Labetalol, Hydralazine, and Nifedipine are administered during pregnancy as they are effective and have low teratogenicity. Starting low dose aspirin before 16 weeks of gestation has been shown to significantly reduce the risk of pre-eclampsia.

Understanding Eclampsia and its Treatment

Eclampsia is a condition that occurs when seizures develop in association with pre-eclampsia, a pregnancy-induced hypertension that is characterized by proteinuria and occurs after 20 weeks of gestation. To prevent seizures in patients with severe pre-eclampsia and treat seizures once they develop, magnesium sulphate is commonly used. However, it is important to note that this medication should only be given once a decision to deliver has been made. In cases of eclampsia, an IV bolus of 4g over 5-10 minutes should be given, followed by an infusion of 1g/hour. During treatment, it is crucial to monitor urine output, reflexes, respiratory rate, and oxygen saturations. Respiratory depression can occur, and calcium gluconate is the first-line treatment for magnesium sulphate-induced respiratory depression. Treatment should continue for 24 hours after the last seizure or delivery, as around 40% of seizures occur post-partum. Additionally, fluid restriction is necessary to avoid the potentially serious consequences of fluid overload.

In summary, understanding the development of eclampsia and its treatment is crucial in managing this potentially life-threatening condition. Magnesium sulphate is the primary medication used to prevent and treat seizures, but it should only be given once a decision to deliver has been made. Monitoring vital signs and urine output is essential during treatment, and calcium gluconate should be readily available in case of respiratory depression. Finally, fluid restriction is necessary to avoid complications associated with fluid overload.

1. The Bishop’s score rates the cervix out of 10, with a higher score indicating a more favorable cervix and a greater likelihood of spontaneous birth. A score below 5 suggests that labor is unlikely to begin without induction.

2. This is not a reason to induce labor.

3. It is recommended that women with uncomplicated pregnancies be offered induction between 41-42 weeks to prevent the risks associated with prolonged pregnancy.

4. A previous classical Caesarean section is an absolute contraindication for inducing labor.

5. Inducing labor is not advisable when the fetus is in a breech position.

Reference: NICE guidelines – Inducing labor and Antenatal care for uncomplicated pregnancies.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

The Importance of Breastfeeding and Weaning

Breastfeeding is crucial for a child’s development and should begin within the first hour of life, according to the WHO and UNICEF. For the first six months, exclusive breastfeeding is recommended, with the baby receiving only breast milk for nutrition. Breastfeeding should occur on demand, and breast milk provides numerous benefits for the child’s cognitive, motor, and immune system development.

After six months, weaning should begin with the introduction of solid foods, while breast milk continues to provide at least half of the child’s nutrition. The WHO recommends breastfeeding for up to two years of age or beyond, with breast milk providing at least one-third of the child’s nutrition in the second year of life.

Overall, breastfeeding and weaning play a crucial role in a child’s growth and development, and it is important to follow the recommended guidelines for optimal health outcomes.

Fetal fibronectin (fFN) is a protein that is released from the gestational sac and is associated with early labor if levels are high. However, a positive result does not guarantee premature labor. Obstetric teams can use this information to prepare for the possibility of premature labor by informing neonatal intensive care and administering steroids to aid in neonatal lung maturity. In this case, the patient is at high risk for premature labor and experiencing tightenings, so further monitoring is necessary before discharge.

Antibiotics may be necessary if the patient had spontaneously ruptured her membranes, but in this case, a history of watery discharge without fluid seen on speculum examination and a closed os is not enough to initiate antibiotic therapy. However, swabs and urine cultures should be obtained to screen for infection and treat as appropriate since infection can be a factor in premature labor.

Administering steroids can cause hyperglycemia in diabetics, so blood glucose measurements should be closely monitored. Hyperglycemia in the mother can have adverse effects on the fetus, so hourly blood glucose measurements should be taken, and additional insulin given as needed. If blood glucose levels are difficult to control, a sliding scale should be initiated according to local protocol.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Pregnant women with a BMI greater than 30 kg/m2 should receive a high dose of 5mg folic acid to prevent neural tube defects. In this case, the patient’s blood pressure is not high enough to require treatment with labetalol. Aspirin 75 milligrams is typically given to pregnant women starting at 12 weeks to lower the risk of pre-eclampsia, but this patient does not have any risk factors for pre-eclampsia and is not currently experiencing hypertension. If the patient had a healthy BMI, they would be prescribed the standard dose of 400 micrograms of folic acid to reduce the risk of neural tube defects.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. It is found in green, leafy vegetables and plays a crucial role in the transfer of 1-carbon units to essential substrates involved in the synthesis of DNA and RNA. However, certain factors such as phenytoin, methotrexate, pregnancy, and alcohol excess can cause a deficiency in folic acid. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, it is recommended that all women take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if they or their partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with certain medical conditions such as coeliac disease, diabetes, or thalassaemia trait, or those taking antiepileptic drugs, or who are obese (BMI of 30 kg/m2 or more) are also considered higher risk.

In summary, folic acid is an essential nutrient that plays a crucial role in DNA and RNA synthesis. Deficiency in folic acid can lead to serious health consequences, including neural tube defects. However, taking folic acid supplements during pregnancy can prevent these defects and ensure a healthy pregnancy.

If high blood pressure occurs after 20 weeks gestation and there is no proteinuria, it is considered gestational hypertension. However, if high blood pressure is present before 20 weeks, it is likely pre-existing hypertension.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

The combined test is a screening test offered between weeks 11 and the end of the 13th week to assess the chance of fetal anomalies. While there is a small risk of miscarriage associated with diagnostic tests (such as amniocentesis and chorionic villus sampling), it is generally considered acceptable when a screening test indicates a high chance of anomaly. However, as Katie is now outside of the window for the combined test, repeating it would not be useful. Instead, it is more appropriate to progress to a diagnostic test. The quadruple test is another screening test offered between weeks 14-19, but repeating a screening test would not confirm or rule out a diagnosis. Therefore, a diagnostic test would be the next step for Katie.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

When a pregnant woman is exposed to chickenpox, the first step is to check if she has varicella antibodies. If she is unsure whether she has had chickenpox in the past, the presence or absence of antibodies will determine the next course of action.

If a pregnant woman is over 20 weeks gestation and does not have varicella antibodies, she should be given varicella-zoster immunoglobulin or oral acyclovir within 7-14 days of exposure. Delaying the administration of oral acyclovir can reduce the risk of developing chickenpox.

Oral acyclovir is also recommended if a pregnant woman over 20 weeks gestation develops chickenpox. However, caution should be exercised if the patient is under 20 weeks gestation and does not have any symptoms of chickenpox.

The varicella-zoster vaccine is not recommended for pregnant women as it is a live attenuated vaccine that can cross the placenta and cause foetal varicella syndrome. It can be given to women who have not had chickenpox and are not immune to antibody testing, but they should avoid getting pregnant for three months after receiving the vaccine.

Varicella-zoster immunoglobulin is recommended for pregnant women who are not immune to varicella on antibody testing and can receive it within 10 days of exposure. However, it provides short-lived protection, so patients should be advised to get the varicella-zoster vaccine after their pregnancy.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

1: The occiput posterior (OP) position during delivery is feasible, but it may result in a longer and more painful labor.
2: If labor progress is slow, augmentation should be considered.
3: The use of Kielland’s forceps is linked to the most favorable outcomes, but it requires specialized skills.
4: Typically, women in the OP position will feel the urge to push earlier than those in the occiput anterior (OA) position.

Labour is divided into three stages, with stage 2 being from full dilation to delivery of the fetus. This stage can be further divided into two categories: passive second stage, which occurs without pushing, and active second stage, which involves the process of maternal pushing. The active second stage is less painful than the first stage, as pushing can mask the pain. This stage typically lasts around one hour, but if it lasts longer than that, medical interventions such as Ventouse extraction, forceps delivery, or caesarean section may be necessary. Episiotomy, a surgical cut made in the perineum to widen the vaginal opening, may also be required during crowning. However, this stage is associated with transient fetal bradycardia, which is a temporary decrease in the fetal heart rate.

To prevent bacterial sepsis in newborns, maternal intravenous antibiotic prophylaxis should be provided to women who have previously given birth to a baby with early- or late-onset GBS disease. GBS is a common cause of sepsis in newborns, particularly in preterm infants with a birth weight of less than 1500 g. GBS is a commensal of the female genital tract and can cause urinary tract infections, septic abortion, and postpartum endometritis in mothers. In newborns, GBS can cause early or late infection, and antibiotics should be administered if signs of sepsis are present at birth.

Group B Streptococcus (GBS) is a common cause of severe infection in newborns. It is estimated that 20-40% of mothers carry GBS in their bowel flora, which can be passed on to their infants during labor and lead to serious infections. Prematurity, prolonged rupture of membranes, previous sibling GBS infection, and maternal pyrexia are all risk factors for GBS infection. The Royal College of Obstetricians and Gynaecologists (RCOG) has published guidelines on GBS management, which include not offering universal screening for GBS to all women and not offering screening based on maternal request. Women who have had GBS detected in a previous pregnancy should be offered intrapartum antibiotic prophylaxis (IAP) or testing in late pregnancy and antibiotics if still positive. IAP should also be offered to women with a previous baby with GBS disease, women in preterm labor, and women with a fever during labor. Benzylpenicillin is the preferred antibiotic for GBS prophylaxis.

Different Types of Miscarriage: Symptoms and Diagnosis

Miscarriage is the loss of pregnancy before 20 weeks’ gestation. There are several types of miscarriage, each with its own symptoms and diagnosis.

Missed miscarriage is an incidental finding where the patient presents without symptoms, but the ultrasound shows a small gestational sac and no fetal heart rate.

Complete miscarriage is when all products of conception have been passed, and the uterus is empty and contracted.

Incomplete miscarriage is when some, but not all, products of conception have been expelled, and the patient experiences vaginal bleeding with an open or closed os.

Inevitable miscarriage is when the pregnancy will inevitably be lost, and the patient presents with active bleeding, abdominal pain, and an open cervical os.

Threatened miscarriage is when there is an episode of bleeding, but the pregnancy is unaffected, and the patient experiences cyclical abdominal pain and dark red-brown bleeding. The cervical os is closed, and ultrasound confirms the presence of a gestational sac and fetal heart rate.

It is important to seek medical attention if any symptoms of miscarriage occur.

A vaginal delivery is expected to be challenging due to the foetal presentation and station. Singleton pregnancies are not recommended for breech extraction, which also demands expertise. Hence, it is advisable to opt for a Caesarean section.

Breech presentation occurs when the caudal end of the fetus is in the lower segment, and it is more common at 28 weeks than near term. Risk factors include uterine malformations, placenta praevia, and fetal abnormalities. Management options include spontaneous turning, external cephalic version (ECV), planned caesarean section, or vaginal delivery. The RCOG recommends informing women that planned caesarean section reduces perinatal mortality and early neonatal morbidity, but there is no evidence that the long-term health of babies is influenced by how they are born. ECV is contraindicated in certain cases, such as where caesarean delivery is required or there is an abnormal cardiotocography.

Risk Factors for Pre-eclampsia in Pregnancy

Pre-eclampsia is a serious disorder of pregnancy that can lead to life-threatening complications if left untreated. It is important to identify risk factors for pre-eclampsia in order to provide appropriate monitoring and care for pregnant women.

Known hypertension is a significant risk factor for pre-eclampsia. Women with hypertension should be closely monitored throughout their pregnancy.

Age is also a factor, with women over 40 being at increased risk. However, the patient in this scenario is 28 years old and not at increased risk.

First pregnancy or first pregnancy with a new partner is a risk factor for pre-eclampsia. However, as this is the patient’s second pregnancy with the same partner, she is not at increased risk.

A high BMI is a risk factor for pre-eclampsia, particularly if a patient’s BMI is over 35. However, a low BMI, such as the patient’s BMI of 17, is not a risk factor.

Finally, a period of ten years or more since the last pregnancy is a moderate risk factor for pre-eclampsia. As the patient has a child that is four years old, she is not at increased risk.

In conclusion, identifying and monitoring risk factors for pre-eclampsia is crucial in ensuring the health and safety of pregnant women and their babies.

Folic Acid Supplementation in Pregnancy

Explanation: Folic acid supplementation is recommended for all women who are trying to conceive and during pregnancy to reduce the risk of neural tube defects and other congenital abnormalities. The recommended dose is 400 micrograms daily from the preconception period until the 12th week of gestation. However, women with certain high-risk factors, such as diabetes, a family history of neural tube defects, or obesity, are advised to take a higher dose of 5 mg daily from the preconception period until the 12th week of gestation. It is important to continue folic acid supplementation until the end of the first trimester to ensure proper formation of the brain and other major organs in the body. Side-effects of folic acid treatment may include abdominal distension, reduced appetite, nausea, and exacerbation of pernicious anaemia.

To evaluate a patient with suspected premature rupture of membranes, a thorough medical history should be obtained, including the number of pregnancies. A sterile speculum examination is necessary to check for the accumulation of amniotic fluid in the posterior vaginal vault. Digital examination should be avoided to prevent infection. Serum beta-HCG is not recommended, and the patient should have had previous ultrasound scans and have confirmed her pregnancy by this stage. Ultrasound is the appropriate diagnostic tool if there is no evidence of amniotic fluid pooling in the posterior vaginal vault.

Preterm prelabour rupture of the membranes (PPROM) is a condition that occurs in approximately 2% of pregnancies, but it is responsible for around 40% of preterm deliveries. This condition can lead to various complications, including prematurity, infection, and pulmonary hypoplasia in the fetus, as well as chorioamnionitis in the mother. To confirm PPROM, a sterile speculum examination should be performed to check for pooling of amniotic fluid in the posterior vaginal vault. However, digital examination should be avoided due to the risk of infection. If pooling of fluid is not observed, testing the fluid for placental alpha microglobulin-1 protein (PAMG-1) or insulin-like growth factor binding protein-1 is recommended. Ultrasound may also be useful to show oligohydramnios.

The management of PPROM involves admission and regular observations to ensure that chorioamnionitis is not developing. Oral erythromycin should be given for ten days, and antenatal corticosteroids should be administered to reduce the risk of respiratory distress syndrome. Delivery should be considered at 34 weeks of gestation, but there is a trade-off between an increased risk of maternal chorioamnionitis and a decreased risk of respiratory distress syndrome as the pregnancy progresses. PPROM is a serious condition that requires prompt diagnosis and management to minimize the risk of complications for both the mother and the fetus.

The situation involves cord prolapse leading to cord compression and variable decelerations on the CTG. The RCOG has issued guidelines (Green-top Guidelines No.50) for managing cord prolapse. The guidelines recommend elevating the presenting part either manually or by filling the urinary bladder to prevent cord compression. If fetal heart rate anomalies persist despite using mechanical methods to prevent compression, tocolysis (such as terbutaline) can be considered while preparing for a caesarean section.

Understanding Umbilical Cord Prolapse

Umbilical cord prolapse is a rare but serious complication that can occur during delivery. It happens when the umbilical cord descends ahead of the presenting part of the fetus, which can lead to compression or spasm of the cord. This can cause fetal hypoxia and potentially irreversible damage or death. Certain factors increase the risk of cord prolapse, such as prematurity, multiparity, polyhydramnios, twin pregnancy, cephalopelvic disproportion, and abnormal presentations like breech or transverse lie.

Around half of all cord prolapses occur when the membranes are artificially ruptured. Diagnosis is usually made when the fetal heart rate becomes abnormal and the cord is palpable vaginally or visible beyond the introitus. Cord prolapse is an obstetric emergency that requires immediate management. The presenting part of the fetus may be pushed back into the uterus to avoid compression, and the cord should be kept warm and moist to prevent vasospasm. The patient may be asked to go on all fours or assume the left lateral position until preparations for an immediate caesarian section have been carried out. Tocolytics may be used to reduce uterine contractions, and retrofilling the bladder with saline can help elevate the presenting part. Although caesarian section is the usual first-line method of delivery, an instrumental vaginal delivery may be possible if the cervix is fully dilated and the head is low.

In conclusion, umbilical cord prolapse is a rare but serious complication that requires prompt recognition and management. Understanding the risk factors and appropriate interventions can help reduce the incidence of fetal mortality associated with this condition.

This patient has intrahepatic cholestasis of pregnancy, which is characterized by abnormal liver function tests and severe itching in the third trimester. This condition increases the risk of stillbirth and maternal complications, particularly after 37 weeks of gestation. Therefore, induction of labor is typically recommended at this point, especially for patients with elevated transaminases and bile acids. While increased fetal monitoring is advised, hospitalization is not necessary unless there are signs of immediate concern for the fetus. A vaginal birth is usually appropriate, and a cesarean section is rarely required unless there are indications of non-reassuring fetal status. Although antihistamines can provide symptomatic relief, they are not sufficient on their own due to the risks associated with this condition. Other options for symptom relief include ursodeoxycholic acid, cholestyramine, and topical emollients. There is no indication for immediate delivery, as fetal movements and ultrasound results are normal.

Intrahepatic Cholestasis of Pregnancy: Symptoms and Management

Intrahepatic cholestasis of pregnancy, also known as obstetric cholestasis, is a condition that affects approximately 1% of pregnancies in the UK. It is characterized by intense itching, particularly on the palms, soles, and abdomen, and may also result in clinically detectable jaundice in around 20% of patients. Raised bilirubin levels are seen in over 90% of cases.

The management of intrahepatic cholestasis of pregnancy typically involves induction of labor at 37-38 weeks, although this practice may not be evidence-based. Ursodeoxycholic acid is also widely used, although the evidence base for its effectiveness is not clear. Additionally, vitamin K supplementation may be recommended.

It is important to note that the recurrence rate of intrahepatic cholestasis of pregnancy in subsequent pregnancies is high, ranging from 45-90%. Therefore, close monitoring and management are necessary for women who have experienced this condition in the past.

Breastfeeding women can safely take sertraline or paroxetine as their preferred SSRIs. These medications are known to have minimal to low levels of exposure to infants through breast milk, and are not considered harmful to them. Therefore, if a mother is diagnosed with postnatal depression and requires antidepressant treatment, she should not be advised to stop breastfeeding.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

It is recommended to wait until the lady reaches 36 weeks of pregnancy to check if the baby has changed position, as she is currently only 30 weeks pregnant. For nulliparous women, such as the lady in this case, ECV should be provided at 36 weeks if the baby remains in the breech position. However, if the lady had previous pregnancies, ECV would be offered at 37 weeks.

Breech presentation occurs when the caudal end of the fetus is in the lower segment, and it is more common at 28 weeks than near term. Risk factors include uterine malformations, placenta praevia, and fetal abnormalities. Management options include spontaneous turning, external cephalic version (ECV), planned caesarean section, or vaginal delivery. The RCOG recommends informing women that planned caesarean section reduces perinatal mortality and early neonatal morbidity, but there is no evidence that the long-term health of babies is influenced by how they are born. ECV is contraindicated in certain cases, such as where caesarean delivery is required or there is an abnormal cardiotocography.

The Importance of Oral Glucose Tolerance Test for Pregnant Women

Pregnant women with risk factors for gestational diabetes should undergo an oral glucose tolerance test at 24-28 weeks, according to National Institute for Health and Care Excellence (NICE) guidelines. Risk factors include a BMI over 30, previous macrosomia, high-risk ethnicity, and family history of diabetes. Women without risk factors do not require the test, while those with one risk factor should undergo the test. If a woman has previously had gestational diabetes, she can monitor her glucose levels or undergo an oral glucose tolerance test as soon as possible after her booking appointment and another test at 24-28 weeks if the first one is normal. HbA1c is not recommended for assessing the risk of gestational diabetes, and fasting blood glucose and random blood glucose tests are not indicated. While a healthy diet is important for all pregnant women, it is insufficient for preventing the development of gestational diabetes. A glucose tolerance test is necessary for diagnosis.

The first step in managing chickenpox exposure during pregnancy is to confirm the patient’s immunity by checking her varicella-zoster antibodies. If the woman is unsure about her past exposure to chickenpox, this test will determine if she has antibodies to the virus. If the test confirms her immunity, no further action is necessary. Administering the varicella-zoster vaccine or IV immunoglobulin is not appropriate in this situation. Neglecting to check the patient’s immunity status can put her and her unborn child at risk.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

The most probable condition is cholestasis of pregnancy, which is indicated by intense itching, jaundice, obstructive liver function tests, normal white blood cell count, and absence of coagulopathy. Severe itching is a typical symptom of cholestasis of pregnancy, while acute fatty liver of pregnancy presents with non-specific symptoms such as fatigue, malaise, and nausea. Given the normal results of the full blood count and viral screening, it is unlikely that the patient has HELLP syndrome or viral hepatitis. Lastly, pre-eclampsia is characterized by high blood pressure and protein in the urine.

Liver Complications During Pregnancy

During pregnancy, there are several liver complications that may arise. One of the most common is intrahepatic cholestasis of pregnancy, which occurs in about 1% of pregnancies and is typically seen in the third trimester. Symptoms include intense itching, especially in the palms and soles, as well as elevated bilirubin levels. Treatment involves the use of ursodeoxycholic acid for relief and weekly liver function tests. Women with this condition are usually induced at 37 weeks to prevent stillbirth, although maternal morbidity is not typically increased.

Another rare complication is acute fatty liver of pregnancy, which may occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea and vomiting, headache, jaundice, and hypoglycemia. Severe cases may result in pre-eclampsia. ALT levels are typically elevated, and support care is the primary management until delivery can be performed once the patient is stabilized.

Finally, conditions such as Gilbert’s and Dubin-Johnson syndrome may be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for haemolysis, elevated liver enzymes, and low platelets, is a serious complication that can occur in the third trimester and requires immediate medical attention. Overall, it is important for pregnant women to be aware of these potential liver complications and to seek medical attention if any symptoms arise.

Diagnosing Gestational Trophoblastic Disease: Differential Diagnosis

Gestational trophoblastic disease is a rare condition that can present with symptoms similar to other pregnancy-related complications. When evaluating a patient with suspected gestational trophoblastic disease, it is important to consider the differential diagnosis and rule out other potential causes.

One common misdiagnosis is occlusion of the coronary vessels, as there is no association between gestational trophoblastic disease and coronary artery disease. Rupture of the fallopian tube may be a possibility if the patient had an ectopic pregnancy, but the history and examination are not suggestive of this. Septic miscarriage is also a possibility, but the symptoms and examination findings in this scenario are more typical of gestational trophoblastic disease.

Twin or triplet pregnancy is unlikely due to the absence of foetal parts and the elevated blood pressure. Instead, gestational trophoblastic disease should be considered when a patient presents with bleeding in early pregnancy, severe hyperemesis, new-onset hypertension prior to 20 weeks’ gestation, and a uterus that is larger than expected. An extremely elevated β-HCG and a classical ultrasound appearance resembling a ‘snow storm’ are also indicative of gestational trophoblastic disease.

It is important to note that gestational trophoblastic disease is strongly associated with thyroid dysfunction and that the lungs are among the first sites of metastatic disease. By considering the differential diagnosis and conducting appropriate testing, healthcare providers can accurately diagnose and treat gestational trophoblastic disease.

Physiological Changes During Pregnancy and Breathlessness: Understanding the Relationship

During pregnancy, a woman’s body undergoes numerous physiological changes that can affect her respiratory system. One of the most significant changes is an increase in tidal volume, which leads to an overall increase in minute ventilation. This increased respiratory workload can result in a feeling of breathlessness, which is experienced by up to 75% of pregnant women, particularly during the first trimester. However, it is important to note that this feeling of breathlessness is typically not indicative of any underlying cardiac or pulmonary issues.

While some degree of dependent leg edema is normal during pregnancy, it is important to understand that other respiratory changes, such as a decrease in residual volume or a reduction in functional residual capacity, do not typically contribute to the feeling of breathlessness. Respiratory rate usually remains unchanged during pregnancy.

Overall, understanding the physiological changes that occur during pregnancy and their impact on the respiratory system can help healthcare providers better manage and address any concerns related to breathlessness in pregnant women.

Measuring Uterine Growth During Pregnancy

During pregnancy, the size of the uterus can be used to estimate the gestational age of the fetus. At around 20 weeks, the uterus reaches the level of the umbilicus. This can be measured using the symphysio-fundal height (SFH), which is usually equal to the number of weeks of gestation (± 2 cm). To measure the SFH, the fundus of the uterus is first palpated and the tape measure is placed at this point. The tape measure is then rolled over the longitudinal axis of the uterus until it reaches the pubic symphysis, and the length in centimeters is recorded.

At 16 weeks, the uterus would not be palpable at the level of the umbilicus. The fundus of the uterus can be palpated at the midpoint between the umbilicus and the pubic symphysis. Similarly, at 18 weeks, the uterus would not be palpable at the level of the umbilicus.

By 22 weeks, the uterus would be past the level of the umbilicus. And by 24 weeks, the uterus would be higher in the abdomen than the umbilicus. Regular measurement of the SFH can help monitor fetal growth and ensure that the pregnancy is progressing normally.